BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED
See where this supplier wins, what is coming up for renewal and where you may have room to challenge.
SUPPLIER PERFORMANCE PASSPORT
No published pressure signals found
No poor performance, breach, contract change or termination record is currently linked to this supplier.
Commercial readNo strong supplier-pressure or challenger-opening pattern is visible yet. Treat timing and account fit as the main reasons to monitor this supplier.
6Contracts found
Value not publishedValue expiring ≤12m
0High-priority ≤12m
0Strong openings ≤12m
See the full supplier picture
Pro shows the full buyer map, lifecycle pressure and every upcoming incumbent position.
Compare plans →Where do they win?
Where could you challenge them?
YERVOY (IPILIMUMAB) CONCENTRATE FOR SOLUTION FOR INFUSION vial, PACK OF 1
Priority 75/100
OPDIVO (NIVOLUMAB) 600MG/5ML SOLUTION FOR INJECTION VIAL, 5 mL
Priority 75/100